FindTrial
Sign In

The Effect of Ghritabhrushta Lodhra Bidalaka in the Management of Allergic Conjunctivitis.

A Randomized Controlled Clinical Trial To Study The Effect Of Ghritabhrushta Lodhra Bidalaka In Vataja Abhishyanda With Special Reference To Simple Allergic Conjunctivitis. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/102722
Enrollment
70
Registered
2026-02-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

None listed

Sponsors

Dr Pratik Pandit Khewalkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having classical signs and symptoms of Vataja Abhishyanda(Simple Allergic Conjunctivitis). 2. Patients having Age between 18 years to 60 years. 3. Unilateral and Bilateral Vataja Abhishyanda.

Exclusion criteria

Exclusion criteria: 1. Patients with Abhighataja Netra Roga. 2. Patients using contact lenses. 3. Patients having chalazion, trachoma, Refractive surgery, Post Operative Cataract surgery. 4. Patient having disease other than Vataja Abhishyanda.

Design outcomes

Primary

MeasureTime frame
Reduction in Signs and Symptoms of disease before and after treatment.Timepoint: 7 Days—

Secondary

MeasureTime frame
Where the trial group stands in comparison to control group in reduction of signs and symptoms of Vataja Abhishyanda.Timepoint: 18 months—

Countries

India

Contacts

Public ContactDr Pratik Pandit Khewalkar

SMBT Ayurved College and Hospital,Dhamangaon, Igatpuri, Nashik 422403

dr.tusharfirke@gmail.com9823388720

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026